Spots Global Cancer Trial Database for gemcitabine injection
Every month we try and update this database with for gemcitabine injection cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Camrelizumab Combined With Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer | NCT04498689 | Metastatic Panc... | Camrelizumab Nab paclitaxel Gemcitabine Inj... | 18 Years - 75 Years | Fudan University | |
| Efficacy and Safety of Camrelizumab Combined With Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer | NCT04498689 | Metastatic Panc... | Camrelizumab Nab paclitaxel Gemcitabine Inj... | 18 Years - 75 Years | Fudan University | |
| CNCT19 Following ASCT in Patients With Relapsed or Refractory B-cell Lymphoma | NCT04690192 | Large B-cell Ly... | CNCT19 Gemcitabine Inj... busulfan Melphalan Injec... | 18 Years - 65 Years | Institute of Hematology & Blood Diseases Hospital, China | |
| Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer | NCT01631357 | Non-small Cell ... Squamous Cell C... | CIK cell Gemcitabine Inj... Cisplatin injec... | 18 Years - 80 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer | NCT06241781 | Adult | GT101 injection Gemcitabine inj... | 18 Years - 70 Years | Grit Biotechnology | |
| Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer | NCT03412799 | Pancreatic Canc... Pancreatic Canc... Stage IV Pancre... | SBP-101 nab-paclitaxel Gemcitabine Inj... | 18 Years - | Panbela Therapeutics, Inc. | |
| Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrahepatic Cholangiocarcinoma | NCT05738057 | Unresectable In... | Camrelizumab Gemcitabine Inj... Cisplatin injec... Cisplatin-Eluti... D-TACE | 18 Years - | Third Affiliated Hospital, Sun Yat-Sen University | |
| CNCT19 Following ASCT in Patients With Relapsed or Refractory B-cell Lymphoma | NCT04690192 | Large B-cell Ly... | CNCT19 Gemcitabine Inj... busulfan Melphalan Injec... | 18 Years - 65 Years | Institute of Hematology & Blood Diseases Hospital, China | |
| Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer | NCT06241781 | Adult | GT101 injection Gemcitabine inj... | 18 Years - 70 Years | Grit Biotechnology | |
| Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer | NCT03412799 | Pancreatic Canc... Pancreatic Canc... Stage IV Pancre... | SBP-101 nab-paclitaxel Gemcitabine Inj... | 18 Years - | Panbela Therapeutics, Inc. | |
| Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer | NCT06241781 | Adult | GT101 injection Gemcitabine inj... | 18 Years - 70 Years | Grit Biotechnology | |
| Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer | NCT06241781 | Adult | GT101 injection Gemcitabine inj... | 18 Years - 70 Years | Grit Biotechnology | |
| A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX | NCT03450018 | Metastatic Panc... | SLC-0111 Gemcitabine Inj... | 18 Years - | British Columbia Cancer Agency |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
